ADMA
NASD ADMA Biologics, Inc.$9.72 ↑ +0.00 (+0.00%) Trading Up from the previous close of $9.72, $0.57 below the day’s high of $10.29
- YTD change
- -46.71%
- vs 20-day SMA
- +2.60%
- vs 200-day SMA
- -17.63%
Price ranges
Price & Performance
+0.44 (+4.74%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 62.1% away from all-time highs of $25.67
- ADMA is down 47% since the beginning of the year
- ADMA is down 33% over the past 12 months
- ADMA is up 2% over the past 1 month
- 11% of all ADMA investors are betting against ADMA
ADMA reads not so good: price sits above one of the two key moving averages, the 12-month move is -33.7%.
- Previous minute
- +$0.00
- Last hour
- -$0.07
- Last 5 days
- +2.10%
- vs 8-day SMA
- -0.88%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
